Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-08-25

著者

• Murphy Christopher

  Activbiotics Inc.

• Van Duzer

  Activbiotics Inc.

• ROTHSTEIN David

  ActivBiotics, Inc.

• MULLIN Steve

  ActivBiotics, Inc.

• SIROKMAN Klari

  Gwathmey Inc.

• SONDERGAARD Karen

  Gwathmey Inc.

• JOHNSON Starrla

  Gwathmey Inc.

• GWATHMEY Judith

  Gwathmey Inc.

• Mullin Steve

  Activbiotics Inc.

• Rothstein David

  Activbiotics Inc.

• MURPHY Christopher

  ActivBiotics, Inc.

関連論文

• Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization
• In Vitro Activity of Novel Rifamycins against Gram-positive Clinical Isolates
• Rifalazil Retains Activity Against Rifampin-resistant Mutants of Chlamydia pneumoniae
• Enhanced Activity of Rifalazil in Combination with Levofloxacin, Linezolid, or Mupirocin against Staphylococcus aureus In Vitro
• In Vitro Time-kill Activities of Rifalazil, Alone and in Combination with Vancomycin, against Logarithmic and Stationary Cultures of Staphylococcus aureus

スポンサーリンク